September 2, 2020
CareATC, a leader in workforce population health management, has signed an agreement with Cancer Treatment Centers of America (CTCA), making CTCA® its preferred oncology care provider. Effective Tuesday, September 1, 2020, many CareATC clients can...
Read MoreMay 21, 2020
The COVID-19 pandemic has caused disruption in oncology care and is creating a cancer “shadow curve” that may result in a dramatic spike in undiagnosed and untreated cancer cases as a side-effect of the pandemic. The US has already witnessed a 37...
Read MoreMarch 15, 2020
Cancer Treatment Centers of America® (CTCA) Chicago has signed an agreement with Aetna, making it a contracted oncology care provider. Effective March 15, 2020, many Aetna commercial members can now select CTCA® Chicago and both Illinois Outpatient...
Read MoreFebruary 12, 2020
Cancer Treatment Centers of America® (CTCA) recently announced that its hospitals located in Chicago, Philadelphia and Tulsa have been named “Top Patient-Recommended Hospitals” in the nation, as reported by Becker's Hospital Review.
Read MoreFebruary 6, 2020
Cancer Treatment Centers of America Atlanta has named Jonathan Watkins, MPA, FACHE, regional president, CTCA Hospitals and Clinics.
Read MoreFebruary 6, 2020
Cancer Treatment Centers of America hospitals in Chicago, Philadelphia and Tulsa were named among the top patient-recommended hospitals in the country, according to the most recent HCAHPS scores.
Read MoreJanuary 30, 2020
For the second year in a row, Cancer Treatment Centers of America® (CTCA) Chicago (Previously known as Cancer Treatment Centers of America at Midwestern Regional Medical Center) is pleased to announce it has received a five-star quality rating from...
Read MoreJanuary 29, 2020
Cancer Treatment Centers of America® (CTCA) has released its seventh annual summary of Patient Treatment Results, a comprehensive presentation of treatment outcomes including length of life, quality of life, the patient experience, and patient...
Read MoreDecember 5, 2019
Investigational medicine NKTR-255 being evaluated for safety and tolerability as monotherapy in patients with relapsed or refractory non-Hodgkin lymphoma or multiple myeloma and in combination with multiple targeted antibodies in multiple myeloma
Read MoreNovember 22, 2019
Cancer Treatment Centers of America® (CTCA) Philadelphia is pleased to announce it has been named a 2019 Guardian of Excellence Award® winner by Press Ganey, a pioneer in health care performance improvement. The Guardian of Excellence Award...
Read MoreCancer Treatment Centers of America® (CTCA) is now City of Hope®, a national, integrated cancer research and treatment system, united to expand patient access to personalized comprehensive cancer care across the United States. Learn what that means for you.